109 related articles for article (PubMed ID: 16940105)
1. Critical design features of phenyl carboxylate-containing polymer microbicides.
Rando RF; Obara S; Osterling MC; Mankowski M; Miller SR; Ferguson ML; Krebs FC; Wigdahl B; Labib M; Kokubo H
Antimicrob Agents Chemother; 2006 Sep; 50(9):3081-9. PubMed ID: 16940105
[TBL] [Abstract][Full Text] [Related]
2. Anti-HIV-1 activity of anionic polymers: a comparative study of candidate microbicides.
Neurath AR; Strick N; Li YY
BMC Infect Dis; 2002 Nov; 2():27. PubMed ID: 12445331
[TBL] [Abstract][Full Text] [Related]
3. Design of a "microbicide" for prevention of sexually transmitted diseases using "inactive" pharmaceutical excipients.
Neurath AR; Strick N; Li YY; Lin K; Jiang S
Biologicals; 1999 Mar; 27(1):11-21. PubMed ID: 10441398
[TBL] [Abstract][Full Text] [Related]
4. Development of cellulose derivatives as novel enteric coating agents soluble at pH 3.5-4.5 and higher.
Kokubo H; Obara S; Minemura K; Tanaka T
Chem Pharm Bull (Tokyo); 1997 Aug; 45(8):1350-3. PubMed ID: 9301034
[TBL] [Abstract][Full Text] [Related]
5. Water dispersible microbicidal cellulose acetate phthalate film.
Neurath AR; Strick N; Li YY
BMC Infect Dis; 2003 Nov; 3():27. PubMed ID: 14617380
[TBL] [Abstract][Full Text] [Related]
6. Cellulose acetate 1,2-benzenedicarboxylate inhibits infection by cell-free and cell-associated primary HIV-1 isolates.
Lu H; Zhao Q; Wallace G; Liu S; He Y; Shattock R; Neurath AR; Jiang BS
AIDS Res Hum Retroviruses; 2006 May; 22(5):411-8. PubMed ID: 16706617
[TBL] [Abstract][Full Text] [Related]
7. Role of seminal plasma in the anti-HIV-1 activity of candidate microbicides.
Neurath AR; Strick N; Li YY
BMC Infect Dis; 2006 Oct; 6():150. PubMed ID: 17042959
[TBL] [Abstract][Full Text] [Related]
8. Combination of candidate microbicides cellulose acetate 1,2-benzenedicarboxylate and UC781 has synergistic and complementary effects against human immunodeficiency virus type 1 infection.
Liu S; Lu H; Neurath AR; Jiang S
Antimicrob Agents Chemother; 2005 May; 49(5):1830-6. PubMed ID: 15855503
[TBL] [Abstract][Full Text] [Related]
9. Electrospun cellulose acetate phthalate fibers for semen induced anti-HIV vaginal drug delivery.
Huang C; Soenen SJ; van Gulck E; Vanham G; Rejman J; Van Calenbergh S; Vervaet C; Coenye T; Verstraelen H; Temmerman M; Demeester J; De Smedt SC
Biomaterials; 2012 Jan; 33(3):962-9. PubMed ID: 22018388
[TBL] [Abstract][Full Text] [Related]
10. Mucosal human defensins 5 and 6 antagonize the anti-HIV activity of candidate polyanion microbicides.
Ding J; Rapista A; Teleshova N; Lu W; Klotman ME; Chang TL
J Innate Immun; 2011; 3(2):208-12. PubMed ID: 21160168
[TBL] [Abstract][Full Text] [Related]
11. Application and removal of polyanionic microbicide compounds enhances subsequent infection by HIV-1.
Pirrone V; Passic S; Wigdahl B; Krebs FC
Virol J; 2012 Jan; 9():33. PubMed ID: 22281044
[TBL] [Abstract][Full Text] [Related]
12. Highly potent and orally active CCR5 antagonists as anti-HIV-1 agents: synthesis and biological activities of 1-benzazocine derivatives containing a sulfoxide moiety.
Seto M; Aikawa K; Miyamoto N; Aramaki Y; Kanzaki N; Takashima K; Kuze Y; Iizawa Y; Baba M; Shiraishi M
J Med Chem; 2006 Mar; 49(6):2037-48. PubMed ID: 16539392
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of pyridin-2-ylmethylaminopiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replication.
Skerlj R; Bridger G; Zhou Y; Bourque E; McEachern E; Langille J; Harwig C; Veale D; Yang W; Li T; Zhu Y; Bey M; Baird I; Sartori M; Metz M; Mosi R; Nelson K; Bodart V; Wong R; Fricker S; Mac Farland R; Huskens D; Schols D
Bioorg Med Chem Lett; 2011 Dec; 21(23):6950-4. PubMed ID: 22033460
[TBL] [Abstract][Full Text] [Related]
14. Lipophile-conjugated sulfated oligosaccharides as novel microbicides against HIV-1.
Said J; Trybala E; Andersson E; Johnstone K; Liu L; Wimmer N; Ferro V; Bergström T
Antiviral Res; 2010 Jun; 86(3):286-95. PubMed ID: 20307578
[TBL] [Abstract][Full Text] [Related]
15. Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro.
Maeda K; Nakata H; Koh Y; Miyakawa T; Ogata H; Takaoka Y; Shibayama S; Sagawa K; Fukushima D; Moravek J; Koyanagi Y; Mitsuya H
J Virol; 2004 Aug; 78(16):8654-62. PubMed ID: 15280474
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of HIV-1 capsid protein assembly inhibitor (CAP-1) and its analogues based on a biomass approach.
Romashov LV; Ananikov VP
Org Biomol Chem; 2016 Dec; 14(45):10593-10598. PubMed ID: 27714265
[TBL] [Abstract][Full Text] [Related]
17. Controlled release polymeric ocular delivery of acyclovir.
Deshpande PB; Dandagi P; Udupa N; Gopal SV; Jain SS; Vasanth SG
Pharm Dev Technol; 2010; 15(4):369-78. PubMed ID: 19772377
[TBL] [Abstract][Full Text] [Related]
18. Repetitive exposures with simian/human immunodeficiency viruses: strategy to study HIV pre-clinical interventions in non-human primates.
Kim CN; Adams DR; Bashirian S; Butera S; Folks TM; Otten RA
J Med Primatol; 2006 Aug; 35(4-5):210-6. PubMed ID: 16872284
[TBL] [Abstract][Full Text] [Related]
19. Blends of reverse enteric polymer with Enteric and pH-independent polymers: mechanistic investigations for tailoring drug release.
Menjoge AR; Kulkarni MG
Biomacromolecules; 2007 Jan; 8(1):240-51. PubMed ID: 17206813
[TBL] [Abstract][Full Text] [Related]
20. Protein promiscuity: drug resistance and native functions--HIV-1 case.
Fernández A; Tawfik DS; Berkhout B; Sanders R; Kloczkowski A; Sen T; Jernigan B
J Biomol Struct Dyn; 2005 Jun; 22(6):615-24. PubMed ID: 15842167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
